Abstract
Pancreatic exocrine insufficiency (PEI) is a common long-term complication after pancreaticoduodenectomy (PD) and is observed in 23–80% of patients. As the postoperative mortality after PD has substantially decreased, it warrants more attention on the diagnosis and treatment of functional long-term consequences after PD. These include PEI and endocrine insufficiency that can result in significant nutritional impairment and often adversely impacts quality of life (QOL) of the patient. A PubMed search was performed for articles using key words “pancreatic exocrine insufficiency”; “pancreaticoduodenectomy”; “quality of life after pancreaticoduodenectomy”; “stool elastase”; “direct, indirect tests for pancreatic exocrine insufficiency”; “pancreatic enzyme replacement therapy.” Relevant studies were shortlisted and analyzed. This review summarizes relevant studies addressing PEI following PD. We also discuss functional changes after PD, risk factors and predictive factors for postoperative PEI, clinical symptoms, direct and indirect tests for estimation of PEI, pancreatic enzyme replacement therapy (PERT), and QOL after pancreatic resection for malignancy. It was found that significant PEI occurs in most patients following PD. Fecal elastase 1 is an easy indirect test and should be performed routinely in both symptomatic and asymptomatic patients after PD. PERT should be considered in every patient after PD with the aim to improve the QOL and perhaps even their long time survival.
References
Dominguez-Munoz JE (2007) Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep 9:116–122
Tseng et al (2016) Pancreatic exocrine insufficiency in patients with pancreatic or periampullary cancer: a systematic review. Pancreas 45:325–330
Bartel MJ et al (2015) Pancreatic exocrine insufficiency in pancreatic cancer. A review of the literature. Dig Liver Dis 47:1013–1020
Gullo L, Pezzilli R, Priori P, Baldoni F, Paparo F, Mattioli G (1987) Pure pancreatic juice collection over 24 consecutive hours. Pancreas. 2:620–623
Scheele G, Bartelt D, Bieger W (1981) Characterization of human exocrine pancreatic proteins by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis. Gastroenterology. 80:461–473
Anagnostides A, Chadwick VS, Selden AC et al (1984) Sham feeding and pancreatic secretion. Evidence for direct vagal stimulation of enzyme output. Gastroenterology. 87:109–114
Perez MM, Newcomer AD, Moertel CG, Go VLW, Dimagno EP (1983) Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer. Cancer 52:346–352
Watanabe S, Shiratori K, Takeuchi T, Chey WY, You CH, Chang TM (1986) Release of cholecystokinin and exocrine pancreatic secretion in response to an elemental diet in human subjects. Dig Dis Sci 31:919–924
Guimbaud R, Moreau JA, Bouisson M, Durand S, Escourrou J, Vaysse N, Frexinos J (1997) Intraduodenal free fatty acids rather than triglycerides are responsible for the release of CCK in humans. Pancreas 14:76–82
Hildebrand P, Petrig C, Burckhardt B, Ketterer S, Lengsfeld H, Fleury A, Hadváry P, Beglinger C (1998) Hydrolysis of dietary fat by pancreatic lipase stimulates cholecystokinin release. Gastroenterology 114:123–129
Ghaneh P, Neoptolemos JP (1999) Exocrine pancreatic function following pancreatectomy. Ann N Y Acad Sci 880:308–318
van Berge Henegouwen MI, van Gulik TM et al (1997) Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 185:373–379
Tran KT, Smeenk HG, van Eijck CH, Kazemier G et al (2004) Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Ann Surg 240:738–745
Shan YS, Sy ED, Tsai ML, Tang LY, Li PS, Lin PW (2005) Effects of somatostatin prophylaxis after pylorus-preserving pancreaticoduodenectomy: increased delayed gastric emptying and reduced plasma motilin. World J Surg 29:1319–1324
Kamiya T, Kobayashi Y, Hirako M, Misu N, Nagao T, Hara M, Matsuhisa E, Ando T, Adachi H, Sakuma N, Kimura G (2002) Gastric motility in patients with recurrent gastric ulcers. J Smooth Muscle Res 38:1–9
Kimura F, Suwa T, Sugiura T, Shinoda T, Miyazaki M, Itoh H (2002) Sepsis delays gastric emptying following pylorus-preserving pancreaticoduodenectomy. Hepatogastroenterology 49:585–588
Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH (2009) Functional changes after pancreatoduodenectomy. Diagnosis and treatment. Pancreatology 9:729–737
DiMagno EP (1979) Medical treatment of pancreatic insufficiency. Mayo Clin Proc 54:435–442
Layer P, Keller J (1999) Pancreatic enzymes, secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol 28:3–10
Lim P-W, Dinh KH, Sullivan M, Wahid Y et al (2016) Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection. HPB. 18:360–366
Singh VK, Haupt ME, Geller DE, Hall JA, Diez PMQ (2017) Less common etiologies of exocrine pancreatic insufficiency. World J Gastroenterol 23:7059–7076
Yuasa Y, Murakami Y, Nakamura H, Uemura K, Ohge H, Sudo T, Hashimoto Y, Nakashima A, Hiyama E, Sueda T (2012) Histological loss of pancreatic exocrine cells correlates with pancreatic exocrine function after pancreatic surgery. Pancreas. 41:928–933
Sato N, Yamaguchi K, Yokohata K et al (1998) Short-term and long-term pancreatic exocrine and endocrine functions after pancreatectomy. Dig Dis Sci 43:2616–2621
Matsumoto J, Traverso LW (2006) Exocrine function following the Whipple operation as assessed by stool elastase. J Gastrointest Surg 10:1225–1229
Nakamura H, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T (2011) Reduced pancreatic parenchymal thickness indicates exocrine pancreatic insufficiency after pancreatoduodenectomy. J Surg Res 171:473–478
Andersen DK (2007) Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis. Pancreas. 35:1–15
McCallum LM, Lamarca A, Valle JW (2016) Prevalence of symptomatic pancreatic exocrine insufficiency in patients with pancreatic malignancy; nutritional intervention may improve survival. Cancer Res Front 2:352–367
Dumasy V, Delhaye M, Cotton F, Deviere J (2004) Fat malabsorption screening in chronic pancreatitis. Am J Gastroenterol 99:1350–1354
Lankisch PG, Droge M, Hofses S, Konig H, Lembcke B (1996) Steatorrhoea, you cannot trust your eyes when it comes to diagnosis. Lancet. 347:1620–1621
DiMagno EP, Go VL, Summerskill WH (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815
Layer P, von der Ohe MR, Holst JJ, Jansen JB, Grandt D, Holtmann G, Goebell H (1997) Altered postprandial, role of malabsorption. Gastroenterology 112:1624–1634
Dujsikova H, Dite P, Tomandl J, Sevcikova A, Precechtelova M (2008) Occurrence of metabolic osteopathy in patients with pancreatitis. Pancreatology 8:583–586
Haas S, Krins S, Knauerhase A, Lohr M (2015) Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP 16:58–62
Mann ST, Mann V, Stracke H, Lange U, Klor HU, Hardt P et al (2008) Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures. Eur J Med Res 13:68–72
Moran CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A et al (1997) Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 92:867–871
Hart PA, Topazian M, Raimondo M, Cruz-Monserrate Z, Fisher WE, Lesinski GB, Steen H, Conwell DL (2016) Endoscopic pancreas fluid collection: methods and relevance for clinical care and translational science. Am J Gastroenterol 111:1258–1266
Schlachterman F (2017) Pancreatic function testing for the early diagnosis of chronic pancreatitis. Gastrointest Endosc 86:1056–1058
Domínguez-Muñoz JE (2011) Pancreatic exocrine insufficiency, diagnosis and treatment. J Gastroenterol Hepatol 26:12–16
Tirkes T, Lin C, Fogel EL, Sherman SS, Wang Q, Sandrasegaran K (2017) T1 mapping for diagnosis of mild chronic pancreatitis. J Magn Reson Imaging 45:1171–1176
Katschinski M, Schirra J, Bross A, Goke B, Arnold R (1997) Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas 15:191–200
Keller J, Aghdassi AA, Lerch MM, Mayerle JV, Layer P (2009) Tests of pancreatic exocrine function - clinical significance in pancreatic and non-pancreatic disorders. Best Pract Res Clin Gastroenterol 23:25–439
Lara LF, Takita M, Burdick JS, DeMarco DC, Pimentel RR, Erim T, Levy MF (2017) A study of the clinical utility of a 20-minute secretin-stimulated endoscopic pancreas function test and performance according to clinical variables. Gastrointest Endosc 86:1048–1055
Keller J, Layer P (2015) Diagnosis of pancreatic exocrine insufficiency in chronic pancreatitis. Am Pancreat Assoc 1:1–7
James O (1973) The Lundh test. Gut. 14:582–591
Lankisch PG, Schreiber A, Otto J (1983) Pancreolauryl test. Evaluation of a tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function. Dig Dis Sci 28:490–493
Beharry S, Ellis L, Corey M, Marcon M, Durie P (2002) How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr 141:84–90
Nandhakumar N, Green MR (2010) Interpretations, how to use faecal elastase testing. Arch Dis Child Educ Pract Ed 95:119–123
Laser et al (1996) Faecal elastase 1, a novel, highly sensitive and specific pancreatic function test. Gut 39:580–586
Stein et al (1996) Faecal immunoreactive elastase 1: evaluation of a new tubeless pancreatic function test in comparison with other indirect and direct tests for exocrine pancreatic function test. Clin Chem 42:222–226
Katschinski et al (1997) Duodenal secretion and faecal excretion of pancreatic elastase 1 in healthy humans and patients with chronic pancreatitis. Pancreas 15:191–200
Walkowiak J, Herzig K-H, Strzykala K, Przyslawski J, Krawczynski M (2002) Fecal elastase-1 is superior to feacal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 110:1–4
Glasbrenner B et al (1996) Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 8:1117–1120
Gullo et al (1999) Faecal elastase 1 determination. Dig Dis Sci 44:210–213
Siegmund E, Lohr JM, Schuff-Werner P (2004) The diagnostic validity of non-invasive pancreatic function tests- a meta-analysis. Z Gastroenterol 42:1117–1128
Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M, Lourido V, Dominguez-Munoz E (2003) Accuracy of the optimized 13C-mixed triglyceride breath test for the diagnosis of steatorrhea in clinical practice. Gastroenterology 124:1
Keller J, Bruckel S, Jahr C, Layer P (2011) A modified 13C-mixed triglyceride breath test detects moderate pancreatic exocrine insufficiency. Pancreas 40:1201–1205
Keller J, Meier V, Wolfram KU, Rosien U, Layer P (2014) Sensitivity and specificity of an abbreviated 13C-mixed triglyceride breath test for measurement of pancreatic exocrine function. United European Gastroenterol J 2:288–294
Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M (2007) 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol 5:484–488
Raman M, Fenton T, Crotty P, Ghosh S, Rioux K, Hundal R (2015) A novel method to identify fat malabsorption: the serum retinyl palmitate test. Clin Chim Acta 438:103–106
Dorsey J, Buckley D, Summer S et al (2010) Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid. J Pediatr Gastroenterol Nutr 50:441–446
Weintraub A, Blau H, Mussaffi H, Picard E, Bentur L, Kerem E, Stankiewicz H, Wilschanski M (2009) Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr 48:306–310
Cameron JL, Riall TS, Coleman JA, Belcher KA (2006) One thousand consecutive pancreaticoduodenectomies. Ann Surg 244:10–15
Pedrazzoli S, Canton SA, Sperti C (2011) Duodenum-preserving versus pylorus-preserving pancreatic head resection for benign and premalignant lesions. J Hepatobiliary Pancreat Sci 18:94–102
Ohtsuka T, Tanaka M, Miyazaki K (2006) Gastrointestinal function and quality of life after pylorus-preserving pancreatoduodenectomy. J Hepato-Biliary-Pancreat Surg 13:218–224
Traverso LW, Longmire WP Jr (1980) Preservation of the pylorus in pancreatico duodenectomy, a follow-up evaluation. Ann Surg 192:306–310
Howard JM, Hess W (2002) Tumors of the ampulla of Vater and pancreas. In: History of the pancreas. Mysteries of a hidden organ. Kluer Academic/Plenum Publishers, New York, pp 421–518
Whipple AO, Parsons WB, Mullins CR (1935) Treatment of carcinoma of ampulla of Vater. Ann Surg 102:763–779
Watson AO (1944) Treatment of carcinoma of the ampulla of Vater: successful radical resection. Br J Surg 31:368–373
Traverso LW, Longmire WP (1980) Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation. Ann Surg 192:306–331
Yamaguchi K, Yokohata K, Nakano K, Ohtani K, Ogawa Y, Chijiiwa K, Tanaka M (2001) Which is a less invasive pancreatic head resection: PD, PPPD, or DPPHR? Dig Dis Sci 46:282–288
Topal B, Fieuws S, Aerts R, Weerts J, Feryn T, Roeyen G, Bertrand C, Hubert C, Janssens M, Closset J (2013) Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy for pancreatic or periampullary tumours: a multicentre randomised trial. Lancet Oncol 14:655–662
He T, Zhao Y, Chen Q, Wang X, Lin H, Han W (2013) Pancreaticojejunostomy versus pancreaticogastrostomy after pancreaticoduodenectomy: a systematic review and meta-analysis. Dig Surg 30:56–69
Lemaire E, O’Toole D, Sauvanet A et al (2000) Functional and morphological changes in the pancreatic remnant following pancreaticoduodenectomy with pancreaticogastric anastomosis. Br J Surg 87:434–438
Nakamura H, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T (2009) Predictive factors for exocrine pancreatic insufficiency after pancreatoduodenectomy with pancreaticogastrostomy. J Gastrointest Surg 13:1321–1327
Jang JY, Kim SW, Park SJ et al (2002) Comparison of the functional outcome after pylorus-preserving pancreatoduodenectomy: pancreatogastrostomy and pancreatojejunostomy. World J Surg 26:366–371
Fogel MR, Gray GM (1973) Starch hydrolysis in man: an intraluminal process not requiring membrane digestion. J Appl Physiol 35:263–267
Halloran CM et al (2011) Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life. A prospective study. Pancreatology 11:535–545
Morera-ocon FJ et al (2014) Considerations on pancreatic exocrine function after pancreaticoduodenectomy. World J Gastrointest Oncol 6:325–329
Sikkens ECM et al (2014) Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function. BJS 101:109–113
Beger HG, Poch B, Mayer B, Siech M (2017) New onset of diabetes and pancreatic exocrine insufficiency after pancreaticoduodenectomy for benign and malignant tumors. Ann Surg 20:1–16
Lyubimova NV, Kosyrev VY, Patyutko YI, Kushlinskii NE (2003) Analysis of elastase 1 for evaluation of excretory function of the pancreas after gastropancreatoduodenal resection. Bull Exp Biol Med 135:34–36
Pessaux P, Aube C, Lebigot J, Tuech JJ, Regenet N, Kapel N, Caron C, Arnaud JP (2002) Permeability and functionality of pancreaticogastrostomy after pancreaticoduodenectomy with dynamic magnetic resonance pancreatography after secretin stimulation. J Am Coll Surg 194:454–462
Mariani A, Mezzi G, Masci E, Soldarini A, Calori G, Zerbi A, Tittobello A (1999) Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods. Pancreas 18:203–211
Durie P, Baillargeon JD, Bouchard S et al (2018) Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel. Curr Med Res Opin 34:25–33
Hart PA, Conwell DL (2018) Challenges and updates in the management of exocrine pancreatic insufficiency. Pancreas 34:25–33
Sabater L, Ausania F, Bakker OJ, Boadas J, Domínguez-Muñoz JE, Falconi M, Fernández-Cruz L, Frulloni L, González-Sánchez V, Lariño-Noia J, Lindkvist B, Lluís F, Morera-Ocón F, Martín-Pérez E, Marra-López C, Moya-Herraiz Á, Neoptolemos JP, Pascual I, Pérez-Aisa Á, Pezzilli R, Ramia JM, Sánchez B, Molero X, Ruiz-Montesinos I, Vaquero EC, de-Madaria E (2016) Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery. Ann Surg 264:949–958
Frulloni L, Falconi M, Gabbrielli A, Gaia E, Graziani R, Pezzilli R et al (2010) Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis 42:381–406
Layer P, Keller J, Lankisch PG (2001) Pancreatic enzyme replacement therapy. Curr Gastroenterol Rep 3:101–108
Bruno MJ, Borm JJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJ et al (1997) Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. Br J Surg 84:952–956
Domínguez-Muñoz JE (2009) Pancreatic enzyme replacement therapy, exocrine pancreatic insufficiency after gastrointestinal surgery. HPB. 11:3–6
Kahl S, Malfertheiner P (2004) Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol 18:947–955
Ghaneh P, Neoptolemos JP (1999) Pancreatic exocrine insufficiency following pancreatic resection. Digestion. 60:104–110
Taylor M (2017) Nutritional and metabolic derangements in pancreatic cancer and pancreatic resection. Nutrients 9:243
Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, Turner R, Nikfarjam M, Rayner C, Horowitz M, Holtmann G, Talley N, Windsor J, Pirola R, Neale R (2016) Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology 16:164–180
Nguyen TC, Sohn TA, Cameron JL, Lillemoe KD, Campbell KA et al (2003) Standard vs radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors. J Gastrointest Surg 7:1–9
Schniewind B, Bestmann B, Henne-Bruns D, Faendrich F, Kremer B, Kuechler T (2006) Quality of life after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head. Br J Surg 93:1099–1107
Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H, de Haes JC, Gouma DJ (2005) Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 92:471–477
Witzigmann H, Max D, Uhlmann D, Geissler F, Schwarz R, Ludwig S, Lohmann T, Caca K, Keim V, Tannapfel A, Hauss J (2003) Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 134:53–62
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Thogari, K., Tewari, M., Shukla, S.K. et al. Assessment of Exocrine Function of Pancreas Following Pancreaticoduodenectomy. Indian J Surg Oncol 10, 258–267 (2019). https://doi.org/10.1007/s13193-019-00901-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-019-00901-0